NEWS
2023.05.11
Release
ExaWizards and SANKEN, Osaka University Jointly Operationalizes Program Medical Device (SaMD) for Major Neurocognitive Disorder Diagnosis Support
-Basic agreement reached on exclusive development and marketing of AI applications based on patents for medical evaluation-
2023.05.10
Release
“exaBase DX Assessment & Learning” : Releasing “DIA 3.0” Assessment Fully Compliant with Ministry of Economy, Trade and Industry’s “Digital Skill Standards” This Summer
“All-encompassing DX Talent Search and Training: Supporting Two Standards, DX Literacy Standards and DX Promotion Skill Standards”
2023.05.10
Media
Nikkei published an article about “exaBase IR Assistant powered by ChatGPT”
2023.05.10
Release
ExaWizards Starts Accepting Reservations for a Beta Version of “exaBase IR Assistant powered by ChatGPT”
—ChatGPT-enabled efficient IR support, generating assumed questions and answers optimized for each company. Patent pending for the generative process visualization technology that realizes accuracy improvement by the user.
2023.05.08
Release
ExaWizards and Kyoto University Develop Drug Safety Evaluation AI Learning from PMDA Evaluation Results 〜Promote more efficient reporting and evaluation of pharmaceutical products and reduce the number of cases requiring human evaluation〜
2023.05.01
Media
Listed in “100 Startups with a Track Record of Collaboration with Government” by the Ministry of Economy, Trade and Industry.
2023.04.28
Info
【Event】ExaWizards Care & Med Tech Forum 2023 〜Pioneering the next generation of medical healthcare and industrial innovation with AI〜
2023.04.28
Media
The Nikkei Business Daily reports on collaboration with PERSOL Holdings
2023.04.27
Release
ExaWizards Acquires a Patent for Anomaly Detection Technology Combining AI and Optics -AI that detects foreign matter contamination or state changes not detectable with the human eye by recognizing the test object and optimizes the wavelengths of lights applied to it-
2023.04.26
Release